KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Retained Earnings: 2010-2024

Historic Retained Earnings for Emergent BioSolutions (EBS) over the last 15 years, with Dec 2024 value amounting to -$212.4 million.

  • Emergent BioSolutions' Retained Earnings rose 41.91% to -$105.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$105.2 million, marking a year-over-year increase of 41.91%. This contributed to the annual value of -$212.4 million for FY2024, which is 874.31% down from last year.
  • As of FY2024, Emergent BioSolutions' Retained Earnings stood at -$212.4 million, which was down 874.31% from -$21.8 million recorded in FY2023.
  • Emergent BioSolutions' Retained Earnings' 5-year high stood at $950.3 million during FY2021, with a 5-year trough of -$212.4 million in FY2024.
  • In the last 3 years, Emergent BioSolutions' Retained Earnings had a median value of -$21.8 million in 2023 and averaged $168.2 million.
  • In the last 5 years, Emergent BioSolutions' Retained Earnings spiked by 72.33% in 2020 and then slumped by 874.31% in 2024.
  • Emergent BioSolutions' Retained Earnings (Yearly) stood at $726.9 million in 2020, then spiked by 30.73% to $950.3 million in 2021, then declined by 22.27% to $738.7 million in 2022, then plummeted by 102.95% to -$21.8 million in 2023, then tumbled by 874.31% to -$212.4 million in 2024.